SMAD2 and gastric adenocarcinoma: To examine the contribution of differential Smad phosphorylation towards carcinogenesis in gastric cancer, we investigated P-Smad2/3C and P-Smad2/3L levels in 130 patients with gastric adenocarcinoma by immunohistochemistry (IHC).